Forecasting The Future: 9 Analyst Projections For Acadia Healthcare Co
Portfolio Pulse from Benzinga Insights
Acadia Healthcare Co (NASDAQ:ACHC) has been analyzed by 9 analysts, showing a range of sentiments from indifferent to somewhat bullish. The average 12-month price target is $88.0, with a high of $94.00 and a low of $75.00. Analysts have maintained or adjusted their ratings, reflecting their views on the company's market position and financial performance. Acadia Healthcare Co has shown positive revenue growth and strong financial metrics, including a net margin of 9.86% and a debt-to-equity ratio of 0.67.
August 19, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Acadia Healthcare Co has received mixed analyst ratings, with a slight decline in the average price target to $88.0. The company's strong financial performance, including a net margin of 9.86% and a debt-to-equity ratio of 0.67, supports its market position.
The analysis shows a range of analyst sentiments, with most being indifferent. The average price target has slightly decreased, indicating a neutral short-term impact. However, the company's strong financial metrics, such as a high net margin and low debt-to-equity ratio, provide a solid foundation, suggesting stability in its stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100